Zomedica Pharmaceuticals Corp. Announces Year End 2019 Financial Results
Zomedica Corp. Common Shares (ZOM)
US:NYSE Investor Relations:
investors.zomedica.com
Company Research
Source: GlobeNewswire
ANN ARBOR, Mich., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic company, announced consolidated financial results for the year ended December 31, 2019. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under accounting principles generally accepted in the United States of America (“U.S. GAAP”). “During 2019 we made significant progress in the development of TRUFORMA™, our point-of-care biosensor platform. We are focused on completing our development work and commencing commercialization of TRUFORMA™ by the end of 2020,” said Shameze Rampertab, CFO and Interim CEO. Summary Year End 2019 Results Zomedica recorded net loss and comprehensive loss for the year ended December 31, 2019 of $19,784,054 or $0.19 per share, compared to a loss of $16,647,687 or $0.18 per share for the year ended December 31, 2018. Zomedica, which is in the development stage, recorded no r
Show less
Read more
Impact Snapshot
Event Time:
ZOM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZOM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZOM alerts
High impacting Zomedica Corp. Common Shares news events
Weekly update
A roundup of the hottest topics
ZOM
News
- Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer [Yahoo! Finance]Yahoo! Finance
- Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial OfficerAccesswire
- Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024 [Yahoo! Finance]Yahoo! Finance
- Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024Accesswire
- Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform [Yahoo! Finance]Yahoo! Finance
ZOM
Sec Filings
- 12/19/24 - Form 8-K
- 11/26/24 - Form 4/A
- 11/19/24 - Form 8-K
- ZOM's page on the SEC website